Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Stevanato Group S.P.A. (STVN)

Stevanato Group S.P.A. (STVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum Business Wire - Thu Mar 12, 3:45PM CDT

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced...

STVN : 14.18 (-1.12%)
Stevanato: Q4 Earnings Snapshot AP - Wed Mar 4, 5:48AM CST

Stevanato: Q4 Earnings Snapshot

STVN : 14.18 (-1.12%)
Stevanato Group Delivers 7% Revenue Growth (9% at Constant Currency) for Fiscal Year 2025, Including Record Revenue from High-Value Solutions and Expanded Margins Business Wire - Wed Mar 4, 5:30AM CST

- Establishes Fiscal 2026 Guidance -

STVN : 14.18 (-1.12%)
Stevanato Group to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 4, 2026 Business Wire - Thu Feb 19, 5:30AM CST

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced...

STVN : 14.18 (-1.12%)
New York Stock Exchange NYSE in Manhattan by 4kclips via Shutterstock
Stocks Finish Mostly Higher Despite a Plunge in Intel Barchart - Fri Jan 23, 3:34PM CST

The S&P 500 Index ($SPX ) (SPY ) on Friday closed up +0.03%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.58%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.34%. March E-mini...

GOOGL : 290.93 (+0.17%)
AAPL : 252.62 (+0.39%)
B : 38.97 (+2.47%)
AVGO : 318.81 (+0.16%)
HL : 18.36 (+2.40%)
SNDK : 677.86 (-3.50%)
CDE : 17.84 (-2.57%)
ADI : 322.03 (+0.06%)
TXN : 196.77 (+1.10%)
$IUXX : 24,162.98 (+0.67%)
ZNM26 : 110-270s (+0.38%)
MSFT : 371.04 (-0.46%)
Stevanato: Q3 Earnings Snapshot AP - Thu Nov 6, 2025

Stevanato: Q3 Earnings Snapshot

STVN : 14.18 (-1.12%)
Stevanato Group Reports Revenue of €303.2 Million for the Third Quarter of 2025 Business Wire - Thu Nov 6, 2025

Company delivers 9% revenue growth, record revenue from high-value solutions, expanded margins, and maintains fiscal year 2025 guidance

STVN : 14.18 (-1.12%)
Stevanato Group to Participate in Upcoming Investor Conferences Business Wire - Fri Oct 31, 2025

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today...

STVN : 14.18 (-1.12%)
Stevanato Group to Report Third Quarter 2025 Financial Results on November 6, 2025 Business Wire - Wed Oct 22, 2025

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced...

STVN : 14.18 (-1.12%)
Stevanato Group Expands Drug Delivery Systems Capacity to Strengthen Global Integrated Offerings Business Wire - Tue Oct 21, 2025

The investment enhances German facility to deliver more flexible and scalable drug delivery solutions

STVN : 14.18 (-1.12%)

Barchart Exclusives

EchoStar Stock Just Broke Above Its 50-Day Moving Average on SpaceX IPO Hype. Does That Make SATS a Buy? Barchart - 1 hour ago
EchoStar shares soar on reports that SpaceX could file for IPO next week. Here’s why SATS stock remains worth owning in 2026. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.